-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
The NL001/005 project has passed the acceptance inspection by the Beijing Municipal Science and Technology Commission.
Recently, two projects undertaken by Beijing Northland Biotechnology Co., Ltd.—"Preclinical Study of a Novel Targeted Drug Recombinant Human Thymosin β4 for the Treatment of Myocardial Infarction" and "Preclinical Study of a Novel Class I Targeted Recombinant Targeted Fusion Protein for the Treatment of Psoriasis"—successfully passed the acceptance review organized by the Beijing Municipal Science and Technology Commission. Both projects are part of the "Beijing Citizens' Health Project Cultivation" initiative. The project leaders provided the expert panel with a detailed report on the research progress and key findings. After reviewing the completion documents, the expert panel unanimously concluded that the projects had progressed smoothly, fully met all the indicators specified in the task descriptions, achieved the anticipated research objectives, and laid a solid foundation for advancing to clinical studies.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005